Other immunohistochemical studies conducted in our lab on sections from excised human testicular tumors have demonstrated that E2F-1 is strongly expressed in carcinoma in situ (data not submitted), supporting its role in initiating proliferation of SSCs in testis. The gene discussed is E2F1; the disease is in situ carcinoma.